Cardiac stimulant

A cardiac stimulant is a substance which acts as a stimulant of the heart -- for example, via positive chronotropic or inotropic action.

Examples of cardiac stimulant drugs are cocaine^[1] and methamphetamine.

References

↑ Billman, George E. (November 1993). "Intracellular calcium chelator, BAPTA-AM, prevents cocaine-induced ventricular fibrillation". Am. J. Physiol. 265 (5 Pt 2): H1529–35. PMID 8238564.

Pharmacology: major drug groups

Gastrointestinal tract/ metabolism (A)	stomach acid Antacids H₂ antagonists Proton pump inhibitors Antiemetics Laxatives Antidiarrhoeals/Antipropulsives Anti-obesity drugs Anti-diabetics Vitamins Dietary minerals

Blood and blood forming organs (B)	Antithrombotics Antiplatelets Anticoagulants Thrombolytics/fibrinolytics Antihemorrhagics Platelets Coagulants Antifibrinolytics

Cardiovascular system (C)	cardiac therapy/antianginals Cardiac glycosides Antiarrhythmics Cardiac stimulants Antihypertensives Diuretics Vasodilators Beta blockers Calcium channel blockers renin-angiotensin system ACE inhibitors Angiotensin II receptor antagonists Renin inhibitors Antihyperlipidemics Statins Fibrates Bile acid sequestrants

Skin (D)	Emollients Cicatrizants Antipruritics Antipsoriatics Medicated dressings

Genitourinary system (G)	Hormonal contraception Fertility agents SERMs Sex hormones

Endocrine system (H)	Hypothalamic-pituitary hormones Corticosteroids Glucocorticoids Mineralocorticoids Sex hormones Thyroid hormones/Antithyroid agents

Infections and infestations (J, P, QI)	Antimicrobials: Antibacterials (Antimycobacterials) Antifungals Antivirals Antiparasitics Antiprotozoals Anthelmintics Ectoparasiticides IVIG Vaccines

Malignant disease (L01-L02)	Anticancer agents Antimetabolites Alkylating Spindle poisons Antineoplastic Topoisomerase inhibitors

Immune disease (L03-L04)	Immunomodulators Immunostimulants Immunosuppressants

Muscles, bones, and joints (M)	Anabolic steroids Anti-inflammatories NSAIDs Antirheumatics Corticosteroids Muscle relaxants Bisphosphonates

Brain and nervous system (N)	Analgesics Anesthetics General Local Anorectics Anti-ADHD Agents Antiaddictives Anticonvulsants Antidementia Agents Antidepressants Antimigraine Agents Antiparkinson's Agents Antipsychotics Anxiolytics Depressants Entactogens Entheogens Euphoriants Hallucinogens Psychedelics Dissociatives Deliriants Hypnotics/Sedatives Mood Stabilizers Neuroprotectives Nootropics Neurotoxins Orexigenics Serenics Stimulants Wakefulness-Promoting Agents

Respiratory system (R)	Decongestants Bronchodilators Cough medicines H₁ antagonists

Sensory organs (S)	Ophthalmologicals Otologicals

Other ATC (V)	Antidotes Contrast media Radiopharmaceuticals Dressings

Cardiac stimulants excluding cardiac glycosides (C01C)

Adrenergic and
dopaminergic agents

Adrenergic agonists

α	Metaraminol Phenylephrine Methoxamine Norfenefrine Oxedrine Midodrine Mephentermine

β	Dobutamine Arbutamine Isoprenaline Prenalterol

mixed	Amezinium metilsulfate Droxidopa Epinephrine # Norepinephrine Etilefrine

Dopamine agonists

Fenoldopam

Both

Unknown/ungrouped

Phosphodiesterase inhibitors (PDE3I)

Other cardiac stimulants

^#WHO-EM
^‡Withdrawn from market
Clinical trials:
- ^†Phase III
- ^§Never to phase III

This article is issued from Wikipedia - version of the 6/15/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.